Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients

Completed

Conditions studied: Sickle Cell Disease, Thalassemia, Pediatric Cancer

In brief

Red Blood Cell - IMProving trAnsfusions for Chronically Transfused recipients (RBC-IMPACT) is an observational cohort study to assess donor, component, and recipient factors that contribute to RBC efficacy in chronically and episodically transfused patients. The objective of the study is to determine how specific genetic and non-genetic factors in donors and recipients may impact RBC survival after transfusion - in short, what factors on both the donor and recipient side may improve the efficacy of the transfusion.

Key facts

Study ID
NCT05255445
Run by
Westat
People needed
157
Starts
2022-03-16
Expected to finish
2024-03-31
Last updated by the study team
2024-05-17

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.